Kopran
Ticker > Company >

Kopran share price

Kopran Ltd.

NSE: KOPRAN BSE: 524280 SECTOR: Pharmaceuticals & Drugs  67k   147   29

185.76
+4.64 (2.56%)
NSE: Today, 10:34 AM

Price Summary

Today's High

₹ 186.59

Today's Low

₹ 180.91

52 Week High

₹ 369.7

52 Week Low

₹ 155

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 896.95 Cr.

Enterprise Value

₹ 912.24 Cr.

No. of Shares

4.83 Cr.

P/E

26.72

P/B

2.12

Face Value

₹ 10

Div. Yield

1.65 %

Book Value (TTM)

₹  87.62

CASH

₹ 7.42 Cr.

DEBT

₹ 22.71 Cr.

Promoter Holding

44.42 %

EPS (TTM)

₹  6.95

Sales Growth

23.57%

ROE

8.54 %

ROCE

11.36%

Profit Growth

10.83 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year23.57%
3 Year14.84%
5 Year11.41%

Profit Growth

1 Year10.83%
3 Year13.85%
5 Year21.71%

ROE%

1 Year8.54%
3 Year6.79%
5 Year7.04%

ROCE %

1 Year11.36%
3 Year8.81%
5 Year9.6%

Debt/Equity

0.0546

Price to Cash Flow

25.66

Interest Cover Ratio

10.8901

CFO/PAT (5 Yr. Avg.)

0.647853468583241

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 44.42 0.00
Dec 2024 44.46 0.00
Sep 2024 44.49 0.00
Jun 2024 44.49 0.00
Mar 2024 44.49 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 10.8901.
  • The company has an efficient Cash Conversion Cycle of 43.7912 days.
  • Company has a healthy liquidity position with current ratio of 2.2202.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.33375020491827.

 Limitations

  • The company has shown a poor revenue growth of 14.8360964166067% for the Past 3 years.
  • Company has a poor ROE of 6.78811142012919% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 82.33 90.62 49.61 73.53 71.94
Total Expenditure 70.27 75.28 44.33 63.84 60.54
Operating Profit 12.06 15.34 5.28 9.69 11.4
Other Income 1.29 8.15 2.12 1.12 0.75
Interest 1.03 1.78 0.69 0.83 0.99
Depreciation 1.17 1.16 1.2 1.23 1.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 11.16 20.55 5.51 8.75 9.83
Tax 2.65 5.24 1.27 2.14 2.42
Profit After Tax 8.51 15.31 4.25 6.6 7.41
Adjusted EPS (Rs) 1.77 3.18 0.88 1.37 1.54

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 179.29 222.83 204.52 273.09 337.46
Total Expenditure 156.11 192.68 189.26 245.18 300.59
Operating Profit 23.18 30.15 15.26 27.91 36.87
Other Income 1.99 10.46 8.18 16.09 16.77
Interest 5.96 3.81 2.95 2.67 4.5
Depreciation 3.47 4.1 4.32 4.41 4.62
Exceptional Items 0 0 0 0 0
Profit Before Tax 15.73 32.71 16.16 36.92 44.52
Tax 4.51 9.23 4.42 5.66 9.88
Net Profit 11.22 23.47 11.74 31.25 34.64
Adjusted EPS (Rs.) 2.59 5.43 2.44 6.48 7.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 43.25 43.25 48.21 48.21 48.21
Total Reserves 186.42 203.6 330.51 347.38 368.66
Borrowings 9.67 2.36 2.08 2.3 2.23
Other N/C liabilities 2.64 6.17 7.07 7.18 7.24
Current liabilities 83.87 68.57 76.25 100.88 84.54
Total Liabilities 325.85 323.95 464.12 505.95 510.88
Assets
Net Block 42.95 47.44 46.22 47.35 52.02
Capital WIP 0.94 0 0 0 0
Intangible WIP 6.13 2.82 3.1 3.53 4.7
Investments 158.14 158.79 259.43 260.07 261.27
Loans & Advances 3.38 3.74 3.92 4.1 4.71
Other N/C Assets 0.08 0.04 0.14 0.49 0.47
Current Assets 114.23 111.12 151.31 190.41 187.7
Total Assets 325.85 323.95 464.12 505.95 510.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 15.73 32.71 16.16 36.92 44.52
Adjustment 11.64 7.38 4.17 -9.04 2.69
Changes in Assets & Liabilities -13.53 14.1 -54.53 -4.68 -2.41
Tax Paid -3.87 -5.41 -3.61 -6.32 -9.83
Operating Cash Flow 9.97 48.77 -37.8 16.87 34.96
Investing Cash Flow 0.63 -8.51 -100.26 10.05 -6.27
Financing Cash Flow -10.6 -40.14 137.99 -26.13 -24.08
Net Cash Flow 0 0.12 -0.07 0.79 4.61

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 44.49 44.49 44.49 44.46 44.42
hridai susheel somani 0.24 0.24 0.24 0.24 0.24
jaya somani 0.54 0.54 0.54 0.54 0.54
kopran lifestyle limited 0.01 0.01 0.01 0.01 0.01
mr adarsh somani 0.38 0.38 0.38 0.38 0.38
mridula somani 1.64 1.64 1.64 5.29 1.63
nupur somani 0.56 0.56 0.56 0.56 0.56
oricon enterprises limite... - - - - 12.88
panorama finvest pvt ltd 7.88 7.88 7.88 7.88 7.87
parijat shipping and fina... 0.80 0.80 0.80 1.89 1.89
sarvamangal mercantile co... - - - - 6.01
somani kumkum 0.07 0.07 0.07 0.07 0.07
suhrid somani 0.19 0.19 0.19 0.19 0.19
surendra somani 1.24 1.24 1.24 1.24 4.50
susheel somani 1.81 1.81 1.81 0.56 0.56
united shippers ltd 4.56 4.56 4.56 4.56 4.56
vandana somani 0.67 0.72 0.72 0.72 1.43
varun somani 0.57 0.57 0.57 0.72 1.11
g.claridge & company limi... 0.71 0.71 0.71 0.71 -
oricon enterprises ltd 12.90 12.90 12.90 12.89 -
sarvamangal mercantile co... 6.02 6.02 6.02 6.02 -
rajendra somani 3.66 3.66 3.66 - -
hazarimall somani 0.04 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 55.51 55.51 55.51 55.54 55.58
laxminarayan vyapaar p lt... 1.95 1.95 1.56 1.56 1.56
madhuri madhusudan kela .... - - - - 1.46
viraj russell mehta 1.85 1.85 1.85 1.85 1.85
madhuri madhusudan kela 1.04 1.04 1.04 1.04 -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

USFDA concludes surveillance inspection at API unit of Kopran’s arm 29 Apr, 3:10 PM Kopran informs about compliance certificate 8 Apr, 5:27 PM Kopran informs about recording of investors conference 27 Mar, 5:07 PM Kopran informs about trading window closure 27 Mar, 2:37 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran informs about certificate 8 Jan, 5:13 PM Kopran informs about compliances-certificate 10 Oct, 4:15 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran’s arm gets environmental clearance to manufacture synthetic organic chemicals 31 Jul, 2:56 PM Kopran informs about issuance of duplicated share certificate 26 Jul, 5:16 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran informs about details of loss of certificate 19 Mar, 1:01 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran informs about loss of share certificate 17 Jan, 5:19 PM Kopran informs about issue of duplicate share certificate 21 Nov, 3:04 PM Kopran informs about loss of share certificate 17 Nov, 5:15 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran informs about board meeting 26 Oct, 2:40 PM Kopran informs about issuance of duplicate share certificate 19 Oct, 2:35 PM Kopran informs about details of loss of certificate 6 Oct, 4:23 PM Kopran informs about closure of trading window 26 Sep, 4:48 PM Kopran informs about loss of share certificate 22 Sep, 5:22 PM Kopran informs about details of loss of certificate 11 Sep, 4:39 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran informs about PCS certificate 21 Apr, 4:37 PM Kopran informs about details of loss of certificate 23 Feb, 4:50 PM Kopran informs about issuance of duplicate share certificates 18 Feb, 10:58 AM Kopran informs about newspaper publication 13 Feb, 5:09 PM Kopran - Quaterly Results 10 Feb, 2:15 PM Kopran - Quaterly Results 10 Feb, 2:15 PM Kopran - Quaterly Results 10 Feb, 2:15 PM Kopran informs about details of loss of certificate 24 Jan, 4:44 PM Kopran informs about details of loss of certificate 3 Jan, 5:01 PM Kopran informs about loss of share certificate 13 Dec, 2:20 PM Kopran informs about details of loss of certificate 7 Dec, 3:40 PM

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kopran and its performance over the period of time. Kopran stock price today is Rs 185.43.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kopran cash from the operating activity was Rs 34.9599 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kopran has a Debt to Equity ratio of 0.0546 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kopran , the EPS growth was 10.8259 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kopran has OPM of 10.9260563682877 % which is a bad sign for profitability.
     
  • ROE: Kopran have a poor ROE of 8.5372 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kopran is Rs 185.43. One can use valuation calculators of ticker to know if Kopran share price is undervalued or overvalued.
Last Updated on:
Brief about Kopran

Kopran Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Kopran Limited is a leading pharmaceutical company in India, dedicated to manufacturing and marketing a wide range of healthcare products. With a rich history of over three decades, Kopran has emerged as a trusted brand in the pharmaceutical industry. The company focuses on developing and producing high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products.

Share Price - Kopran Limited

Kopran Limited's share price reflects the market valuation of the company's stock. The share price is influenced by various factors such as the company's financial performance, industry trends, and market sentiment. As a long-term stock investor, it is crucial to analyze the share price movement to make informed investment decisions. Our pre-built screening tools allow you to track and analyze the share price of Kopran Limited over time, enabling you to identify potential investment opportunities.

Balance Sheet - Kopran Limited

The balance sheet provides a snapshot of a company's financial position, representing its assets, liabilities, and shareholders' equity. Kopran Limited's balance sheet showcases the company's financial stability and growth prospects. Utilizing our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can calculate the fair value of Kopran Limited's stock based on the balance sheet data. These tools enable investors to assess the company's intrinsic value and make informed investment decisions.

Annual Report - Kopran Limited

The annual report of Kopran Limited provides comprehensive insights into the company's performance, achievements, and future prospects. Our website offers downloadable annual reports for Kopran Limited, allowing investors to analyze the company's financials, management discussions, and outlook. By studying the annual report, investors can gain a deeper understanding of Kopran Limited's business strategies and make informed investment decisions.

Dividend - Kopran Limited

Kopran Limited has a history of rewarding its shareholders through dividends. Dividends are a portion of the company's profits distributed among its shareholders. Monitoring the dividend payout and dividend yield of Kopran Limited can be crucial for long-term investors seeking regular income from their investments. By utilizing our pre-built screening tools, investors can easily track the dividend history and dividend yield of Kopran Limited, helping them make investment decisions aligned with their income goals.

Quarterly Result - Kopran Limited

The quarterly results of Kopran Limited provide updated information on the company's financial performance during a specific three-month period. Investors can evaluate the company's revenue growth, profitability, and other key financial metrics by analyzing the quarterly results. Our website offers quarterly result updates for Kopran Limited, allowing investors to stay informed and assess the company's ongoing performance.

Stock Price - Kopran Limited

The stock price of Kopran Limited represents the market value of the company's shares. Tracking the stock price movement is essential for investors to gauge market sentiment and assess the performance of their investment. Our website provides a price chart that displays the historical stock price movement of Kopran Limited, enabling investors to identify trends and patterns, aiding in their analysis and decision-making process.

News - Kopran Limited

Staying updated with the latest news and developments related to Kopran Limited is crucial for investors. Our website provides a dedicated news section for Kopran Limited, where investors can access relevant news articles, press releases, and corporate announcements. By keeping abreast of the news, investors can stay informed about the company's activities, industry trends, and market dynamics, supporting their investment analysis.

Concall Transcripts - Kopran Limited

Concall transcripts provide valuable insights into the discussions and Q&A sessions that take place during the company's earnings conference calls. Our website offers downloadable concall transcripts for Kopran Limited, allowing investors to read and analyze the discussions between the company's management and analysts. By studying these transcripts, investors can gain a deeper understanding of the company's performance, growth strategies, and future outlook.

Investor Presentations - Kopran Limited

Investor presentations are a valuable resource for understanding a company's business model, growth plans, and financial performance. Kopran Limited provides investor presentations that offer a comprehensive overview of the company's operations, market position, and future prospects. By accessing these downloadable presentations on our website, investors can delve into the details and make informed investment decisions.

Promoters - Kopran Limited

The promoters of Kopran Limited play a crucial role in shaping the company's vision, strategic direction, and overall growth. Our website provides information about the key promoters of Kopran Limited, including their background, experience, and contribution to the company's success. By understanding the promoters' involvement and commitment to the company, investors can assess the company's governance and long-term stability.

Shareholders - Kopran Limited

The shareholders of Kopran Limited are an essential part of the company's ownership structure. Our website offers insights into the major shareholders of Kopran Limited, including institutional investors, mutual funds, and individual investors. By studying the shareholder composition, investors can gain insights into the market perception of the company and identify influential stakeholders who may impact the company's strategic decisions.

In conclusion, the content above provides a comprehensive analysis of Kopran Limited's stock, catering to long-term stock investors seeking detailed information about the company. By utilizing our pre-built screening tools and premium features, investors can access valuable resources such as annual reports, concall transcripts, investor presentations, and more, enabling them to make well-informed investment decisions. 

Kopran's Steady Growth in Reserves

Kopran has demonstrated a consistent increase in total reserves over the last five years. From March 2020 to March 2024, total reserves grew from Rs 186.42 Cr. to a substantial Rs 368.66 Cr. This growth signifies a robust reserve accumulation strategy, underpinning Kopran's financial resilience.

Subdued Borrowings on Kopran's Balance Sheet

Kopran has managed to maintain a low level of borrowings through the years, with a minor uptick from Rs 2.08 Cr. in March 2022 to Rs 2.30 Cr. in March 2023, before slightly decreasing to Rs 2.23 Cr. in March 2024. This indicates a conservative approach to leverage and a focus on maintaining a strong balance sheet.

Expansion in Kopran's Asset Base

The company's total assets have seen a consistent rise, from Rs 325.85 Cr. in March 2020 to Rs 510.88 Cr. by March 2024. Notably, investment assets increased significantly from Rs 158.14 Cr. to Rs 261.27 Cr., showing Kopran's growing asset pool and possible revenue-generating investments.

Kopran's Current Assets and Liabilities

Current assets moved upward, indicating a healthy liquidity position from Rs 114.23 Cr. in March 2020 to Rs 187.70 Cr. in March 2024. However, there was also an increase in current liabilities, particularly between March 2022 and March 2023, before a slight reduction in 2024.

This data presents an analysis for the standalone balance sheet of Kopran. In addition to providing insights for stock screening, understanding a corporation's financial health is a pivotal aspect of evaluating its position relative to market indices such as the NSE or BSE, sector performance, or potential IPO valuations.

Read More
X